“[E]ven on the best medical therapy, left ventricular systolic dysfunction [LVSD] has a high burden of morbidity and mortality,”

— Justin Ezekowitz, director of the heart function clinic at the University of Alberta (Edmonton), discussing his views on the role of devices in heart failure in a presentation at the Heart Failure Society of America meeting being held this week in Washington, “Researcher stumps for analyses to include registry data for ICDs,” pp. 1, 7.

No Comments